Table 4 Quantification of the laboratory markers of the patients evaluated in this study
From: High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection
Marker | ANA-positive | ANA-negative | p-value |
|---|---|---|---|
AST (U/L) | 88.8 ± 76.18 | 65.85 ± 37.88 | 0.2351M |
ALT (U/L) | 85.75 ± 70.29 | 77.59 ± 54.47 | 0.6039T |
GGT (U/L) | 104.87 ± 82.04 | 95.1 ± 92.95 | 0.4705M |
ALP (U/L) | 121.98 ± 51.94 | 119.13 ± 56.18 | 0.8533T |
TB (mg/dL) | 1.29 ± 1.49 | 0.86 ± 0.47 | 0.8300M |
DB (mg/dL) | 0.42 ± 0.44 | 0.27 ± 0.17 | 0.9340M |
IB (mg/dL) | 0.92 ± 1.25 | 0.59 ± 0.38 | 0.3863M |
TP (g/dL) | 7.4 ± 0.7 | 7.57 ± 1.01 | 0.3938M |
Albumin (g/dL) | 4.08 ± 0.54 | 4.23 ± 0.65 | 0.4147T |
Globulin (g/dL) | 3.37 ± 0.76 | 3.42 ± 0.95 | 0.8344T |
PT (%) | 79.75 ± 17.58 | 83.32 ± 20.51 | 0.5536T |
Platelets (× 103) | 173.82 ± 78.6 | 203.2 ± 76.31 | 0.1610T |
VL (log10) | 5.59 ± 0.35 | 5.49 ± 0.84 | 0.8748M |